Everything below concerns LC-MS/MS. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2026-08-01. Where a claim depends on a specific study, the study is described rather than over-claimed.
At the molecular level, GW501516 binds and activates PPARδ, a nuclear receptor that regulates transcription. Activation shifts expression of genes involved in fatty acid oxidation, energy expenditure, and lipid transport in skeletal muscle and liver. Animal studies report increased endurance and altered lipid profiles after exposure. Human data are limited to small trials and do not establish long-term safety or efficacy. PPARδ also has roles in cell proliferation, so the relationship between activation and cancer risk remains an open question.
Published literature on cardarine includes in vitro assays, rodent experiments, and a small number of human studies. Reports describe effects on exercise capacity and lipid metabolism in animals, while human evidence is sparse. Many online descriptions present the compound as a proven endurance aid, a claim not supported by regulatory approval or large clinical trials. Analytical studies focus on identifying the parent compound and its metabolites in biological samples. Important uncertainties include species differences, dose-response relationships, and the relevance of rodent tumor findings to humans.
Cardarine is the common name for GW501516, a synthetic compound studied as a peroxisome proliferator-activated receptor delta agonist. Researchers developed it to explore treatments for lipid disorders and metabolic conditions. It is not an approved medicine in any country. Early clinical work examined changes in HDL cholesterol and triglycerides, but development was discontinued after animal studies raised concerns about cancer. The compound remains available as a research chemical and appears in discussions of performance enhancement.
Cardarine has no approved therapeutic indication and is not marketed as a medicine. The World Anti-Doping Agency lists GW501516 as a prohibited substance at all times, covering both in-competition and out-of-competition periods. National laws vary: some countries treat it as an unapproved drug subject to import controls, while others have specific restrictions on sale for human consumption. It is often sold as a research chemical, a label that does not imply safety or legality. Enforcement actions have targeted online vendors and shipments.
Anti-doping laboratories identify GW501516 and related metabolites using liquid chromatography coupled with tandem mass spectrometry. Urine is the most common matrix, though blood and dried blood spots may also be analyzed. The method targets the parent compound and phase I and phase II metabolites, which extend the detection window. Because the substance is prohibited at all times, athletes can be tested outside competition. Detection limits and windows depend on the assay, sample type, and individual metabolism.
Cardarine is frequently described as a fat-burning or endurance-enhancing supplement, but these claims exceed the available evidence. The compound is not a hormone, steroid, or selective androgen receptor modulator. Research articles discuss it as a tool compound for studying PPARδ biology, while anti-doping literature focuses on its abuse and detection. Quality of unapproved products is uncertain, and independent analyses have found impurities or incorrect labeling. Open questions include whether human cancer risk resembles that seen in rodents and how often non-athletes use the substance.
| Property | Value | Notes |
|---|---|---|
| Common name | Cardarine | Also called GW501516 and endurobol. |
| Chemical formula | C21H18F3NO3S2 | Molecular weight about 453.5 g/mol. |
| Appearance | White to off-white solid | Form depends on synthesis and purity. |
| Solubility | Soluble in DMSO and ethanol | Low solubility in water. |
| Typical storage | -20 °C, desiccated, protected from light | Common for research chemicals. |
Safety concerns emerged from long-term animal studies. In rodents given the compound for extended periods, researchers found an increased incidence of certain cancers, including liver and bladder tumors. These findings contributed to the discontinuation of clinical development. Whether similar risks apply to short-term or low-level exposure in humans is not established, and controlled human safety data are limited. The relevance of high-dose rodent carcinogenicity findings to human use remains a subject of debate.
Human trials of GW501516 were small and short in duration. They examined lipid levels, glucose handling, and other metabolic markers, but the programs were halted after the animal cancer findings. No approved therapeutic product exists, and published human data are insufficient for establishing long-term safety. Reports of use for athletic performance come mainly from non-clinical settings and cannot be verified through controlled trials. Independent testing of products sold as cardarine has found inconsistent purity and labeling.
Laboratory studies indicate that GW501516 activates PPARδ, a nuclear receptor involved in fatty acid oxidation and energy metabolism. In rodent experiments, treated animals often showed increased endurance and reduced fat mass. These effects were observed under controlled conditions and do not establish safe or effective use in humans. The exact dose-response relationship in humans remains poorly characterized. Species differences in metabolism can affect how results translate across animals and people.
Legal status varies by country. In some places, cardarine is controlled under medicines or psychoactive substances laws; in others, it may be sold with minimal oversight as a research chemical. Customs agencies have intercepted shipments, and several national health agencies have issued warnings about products marketed for bodybuilding or performance enhancement. The lack of a standardized pharmaceutical supply means identity, purity, and contamination levels can differ widely between samples. These factors make cardarine a regulatory and public health concern rather than a conventional prescription drug.
Cardarine is a common name for GW501516, a synthetic compound first described in the 1990s as a selective agonist of the peroxisome proliferator-activated receptor delta. It was studied in preclinical models for metabolic and cardiovascular conditions, but it has not been approved as a medicine in the United States, Europe, or other major jurisdictions. Retail products labeled as cardarine are generally research chemicals or supplements, not pharmaceutical formulations. Because human safety and efficacy data remain limited, regulatory agencies treat it as an unapproved substance rather than a therapeutic product.
Sporting authorities added GW501516 to prohibited lists after it appeared in athlete samples and online markets. The World Anti-Doping Agency classifies it as a hormone and metabolic modulator, and its use can lead to an anti-doping rule violation. Some early laboratory work suggested effects on fatty acid oxidation and endurance-related metabolism in animals, but those findings do not establish safe or effective use in people. Reports of adverse events in humans are scarce and often anecdotal, which complicates risk assessment.
Laboratory studies have examined GW501516 in cell cultures and rodents for conditions such as dyslipidemia, insulin resistance, and obesity. Some trials in humans were initiated, but development was discontinued after preclinical findings raised concerns about cancer in certain models. Those findings do not prove that the compound causes cancer in people, but they contributed to regulatory caution. Later reviews often describe the evidence as preliminary and insufficient for assessing long-term safety.
In the fitness and bodybuilding literature, cardarine is frequently discussed as an endurance agent or fat-loss compound, although such claims are not supported by robust clinical evidence. Online descriptions often mix animal data, user anecdotes, and marketing language. Researchers who study PPARδ agonists distinguish between receptor activation in controlled experiments and unsupervised use of unverified products. The latter introduces unknown purity, dose, and interactions, making reported experiences difficult to interpret scientifically.
Major subranges of the Eastern Front include the Black Mountains, Great Craggy Mountains, and Great Balsam Mountains, and its chief summits include Grandfather Mountain 5,964 ft (1,818 m) near the Tennessee-North Carolina border, Mount Mitchell 6,684 ft (2,037 m) in the Blacks, and Black Balsam Knob 6,214 ft (1,894 m) and Cold Mountain 6,030 ft (1,840 m) in the Great Balsams. The Western Blue Ridge Front is subdivided into the Unaka Range, the Bald Mountains, the Great Smoky Mountains, and the Unicoi Mountains, and its major peaks include Roan Mountain 6,285 ft (1,916 m) in the Unakas, Big Bald 5,516 ft (1,681 m) and Max Patch 4,616 ft (1,407 m) in the Bald Mountains, Kuwohi 6,643 ft (2,025 m), Mount Le Conte 6,593 feet (2,010 m), and Mount Guyot 6,621 ft (2,018 m) in the Great Smokies, and Big Frog Mountain 4,224 ft (1,287 m) near the Tennessee-Georgia-North Carolina border. Prominent summits in the cross ridges include Waterrock Knob (6,292 ft (1,918 m)) in the Plott Balsams. Across northern Georgia, numerous peaks exceed 4,000 ft (1,200 m), including Brasstown Bald, the state's highest, at 4,784-and-4,696 ft (1,458-and-1,431 m) Rabun Bald. In north-central Alabama, Mount Cheaha rises prominently to 1,445 feet (440 m) over its surroundings, as part of the southernmost spur of the Blue Ridge Mountains.
is 15 denarii per pound, while that of white pepper is seven, and of black, four." Pliny also complains, "There is no year in which India does not drain the Roman Empire of 50 million sesterces", and further moralises on pepper:
Valerylfentanyl is an opioid analgesic that is an analog of fentanyl and has been sold online as a designer drug. It has been seldom reported on illicit markets and there is little information about it, though it is believed to be less potent than butyrfentanyl but more potent than benzylfentanyl. In one study, it fully substituted for oxycodone and produced antinociception and oxycodone-like discriminative stimulus effects comparable in potency to morphine in mice, but failed to stimulate locomotor activity in mice at doses up to 100 mg/kg.
Sources: en.wikipedia.org
Affectional bond: define relationships in which neither partner is limerent. Limerent–Nonlimerent bond: define relationships in which one partner is limerent. Limerent–Limerent bond: define relationships in which both partners are limerent. The constitution of these bonds may vary over the course of the relationship, in ways that may either increase or decrease the intensity of the limerence. A characteristic of this delineation made by Tennov, is that based on her research and interviews with over 500 people, all human bonded relationships can be divided into three varieties being defined by the amount of limerence or non-limerence each partner contributes to the relationship.
Chromatography is a 2004 post trip-hop album by Second Person. This is the band's debut album and all songs were written by Julia Johnson and Mark Maclaine, except "Word for Word" which also credits Ed Webber and Tristan Kajanus, "Demons Die" which also credits Álvaro López and "Divine" which was written by Julia Johnson. The album was recorded, produced and mixed by Mark Maclaine (aka The Silence) at The Silence Corporation Studios, London. The songs "I Spy" and "My Baby Only Cares For Me" were originally written for the 2003 ski/snowboard film: Snow's in the House 2 and they can be found as earlier incarnations on the film's soundtrack.
=== Temperature and relative humidity === Organic materials are porous by nature, which means that they are greatly affected by changes in the moisture levels of their surroundings. Overly moist conditions can lead to growth of fungi on protein materials like human remains, which is one of the most common risks they face. Alternately, low-humidity conditions can potentially cause protein materials to crack, split, and shrink. Ideal storage conditions for bones is 35% to 55% relative humidity with minimal fluctuations, while ideal conditions for the preservation of mummies are 50 to 59 degrees Fahrenheit (10 to 15 degrees Celsius) with a relative humidity of 40% to 55%.
On April 21, 2009, Newsom announced his candidacy for governor of California in the 2010 election. He named state senator (and future U.S. senator) Alex Padilla to chair his campaign. He received former president Bill Clinton's endorsement in September. Throughout the campaign, he had low poll numbers, trailing Democratic frontrunner Jerry Brown by more than 20 points in most polls. Newsom dropped out of the race in October and ran for lieutenant governor instead.
Sources: en.wikipedia.org
Cardarine is a common name for the investigational compound GW501516. It acts as a PPARδ agonist and is not approved for human use. It is prohibited in sport.
It activates PPARδ, a nuclear receptor that influences gene expression related to lipid and energy metabolism. Animal studies show changes in endurance and lipid levels. Human effects and risks are not well established.
No, cardarine is not a steroid. It belongs to a different chemical class, the PPARδ agonists. It is also not a selective androgen receptor modulator.
Legal status varies by country. It is not approved as a medicine, and it is prohibited in sport. Some jurisdictions restrict import, sale, or possession.